NL-OMON25649尚未招募不适用
Biodistribution and dosimetry of the newly developed P-gp PET tracer [11C]laniquidar in healthy volunteers.
VU University Medical Center0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 6
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Age between 18-65 years;
- •2. Good physical health evaluated by medical history, physical (including neurological) examination and screening laboratory tests;
排除标准
- •1. Any clinical significant abnormality of any clinical laboratory test;
- •2. Any subject who has received any investigational medication within 30 days prior to the start of this study, or who is scheduled to receive an investigational drug;
研究者
相似试验
已完成
不适用
Biodistribution and dosimetry of the newly developed P-gp PET tracer [11C]laniquidar in healthy volunteersNL-OMON35158Vrije Universiteit Medisch Centrum6
已完成
1 期
PK in Pts With HRPC & Skeletal MetastesProstatic NeoplasmsNCT00667537Bayer6
招募中
1 期
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine TumorsNeuroendocrine TumorsNCT06056362Peking Union Medical College Hospital80
招募中
1 期
Application of Al18F-NOTA-Pentixafor PET/CT for Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary AldosteronismNCT06773663Peking Union Medical College Hospital150
尚未招募
1 期
Role of radio-labelled GCC-compounds in diagnosis and treatment planning of colorectal cancerCTRI/2022/11/047568All India Institute of Medical Sciences, New Delhi